QIAGEN NV (QGEN)
44.89
-0.55
(-1.21%)
USD |
NYSE |
Dec 12, 13:57
QIAGEN EPS Diluted (Quarterly): 0.5953 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InflaRx NV | -0.2115 |
| CDT Equity, Inc. | -13.16 |
| LENZ Therapeutics, Inc. | -0.5851 |
| Liminatus Pharma, Inc. | -0.0675 |
| Oruka Therapeutics, Inc. | -0.6871 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 130.04M |
| Revenue (Quarterly) | 532.58M |
| Total Expenses (Quarterly) | 402.54M |
| Enterprise Value | 10.29B |
| Gross Profit Margin (Quarterly) | 61.80% |
| Profit Margin (Quarterly) | 24.42% |
| Earnings Yield | 4.13% |
| Operating Earnings Yield | 5.54% |
| Normalized Earnings Yield | 4.590 |